Comprehensive Genetic Testing for Clinical Decision‐Making in a Patient With Congenital Hyperinsulinism
Genetics Research · 2025
DOI: 10.1155/genr/7281653 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genetics Research, 2025. Verfasst von Matthias Begemann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Genetics and Genomic Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany, rwth-aachen.de. Hauptthemen laut MEDLINE: Congenital Hyperinsulinism, Genetic Testing, Sulfonylurea Receptors, Clinical Decision-Making. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This case study examines a preterm newborn with autosomal recessive ABCC8 gene‐related diffuse congenital hyperinsulinism (CHI). The interdisciplinary management of the patient, including advanced genetic testing and long‐read sequencing, finally led to the molecular diagnosis. These findings were relevant for the immediate decision on further treatment options highlighting the importance of differentiating between focal and diffuse CHI forms, and for providing the family with counseling on the recurrence risks and prenatal diagnostic options. In summary, this study illustrates the clinical and genetic intricacies of CHI, emphasizing the significance of comprehensive genetic analysis in diagnostics and tailored treatment. The case advocates for the integration of state‐of‐the‐art genetic diagnostic technologies in combination with clinical interdisciplinary management to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Human Genetics and Genomic Medicine, Faculty of Medicine, RWTH Aachen University, Aachen, Germany, rwth-aachen.de.
- Department of Pediatrics, Faculty of Medicine, RWTH Aachen University, Aachen, Germany, rwth-aachen.de.
- Pediatric Surgery and Urology, Children's and Youth Hospital Auf der Bult, Hannover, Germany.
- Department of Pediatric Surgery, Protestant Hospital of Bethel Foundation, University Hospital OWL, Campus Bielefeld Bethel, University of Bielefeld, Bielefeld, Germany, uni-bielefeld.de.
- Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany, uni-duesseldorf.de.
- St. Josef-Stift Hospital Sendenhorst, Sendenhorst, Germany.
ORCID-Profile: Matthias Begemann, Thomas Eggermann, Miriam Elbracht, Angeliki Pappa
Zitieren
APA
Begemann, M., Boy, J. A. T., Kraft, F., Vossschulte, H., Barthlen, W., Kummer, S., Orlikowsky, T., Torosoglu, A., Eggermann, T., Kurth, I., Elbracht, M., & Pappa, A. (2025). Comprehensive Genetic Testing for Clinical Decision‐Making in a Patient With Congenital Hyperinsulinism. Genetics Research. https://doi.org/10.1155/genr/7281653
Vancouver
Begemann M, Boy JAT, Kraft F, Vossschulte H, Barthlen W, Kummer S, et al. Comprehensive Genetic Testing for Clinical Decision‐Making in a Patient With Congenital Hyperinsulinism. Genetics Research. 2025. doi:10.1155/genr/7281653
BibTeX
@article{Begemann2025,
author = {Begemann, Matthias and Boy, Johannes Alexander Tobias and Kraft, Florian and Vossschulte, Hendrik and Barthlen, Winfried and Kummer, Sebastian and Orlikowsky, Thorsten and Torosoglu, Adrin and Eggermann, Thomas and Kurth, Ingo and Elbracht, Miriam and Pappa, Angeliki},
title = {Comprehensive Genetic Testing for Clinical Decision‐Making in a Patient With Congenital Hyperinsulinism},
journal = {Genetics Research},
year = {2025},
doi = {10.1155/genr/7281653}
}
EUVIMED